🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 868459108
- Market Cap
- Large Cap · $1 Billion
- IPO
- 5/2/2012 · $5.00/share
Business: Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company is also developing several product candidates to address large market opportunities in psychiatry.
Company Contact
- CEO
- Jack A. Khattar
- CFO
- Gregory S. Patrick
- Headquarters
- 1550 East Gude Drive, Rockville, MD 20850
- Phone
- 301-838-2500
- Investor Relations
- Peter Vozzo, Westwicke Partners · 443-377-4767 · peter.vozzo@westwicke.com